0 NASDAQ Companies - January 4, 2024OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029MIAMI, Jan. 04, 2024 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) (the “Company”) today announced the pricing of its […]Read More
0 NASDAQ Companies - January 4, 2024Dyne Therapeutics Announces Pricing of $300 Million Public Offering of Common StockWALTHAM, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq:DYN), a clinical-stage muscle disease company focused on advancing innovative […]Read More
0 NASDAQ Companies - January 4, 2024Voyager Therapeutics Announces Pricing of Public OfferingLEXINGTON, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic […]Read More
0 NASDAQ Companies - January 4, 2024Standard BioTools Stockholders Approve Merger with SomaLogicSOUTH SAN FRANCISCO, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose […]Read More
0 NASDAQ Companies - January 4, 2024FormFactor Inc. To Present At The 26th Annual Needham Growth ConferenceLIVERMORE, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) — FormFactor, Inc. (Nasdaq: FORM) is pleased to announce its participation in the 26th […]Read More
0 TSX News - January 4, 2024Petrus Resources Announces Monthly Activity UpdateCALGARY, Alberta, Jan. 04, 2024 (GLOBE NEWSWIRE) — Petrus Resources Ltd. (“Petrus” or the “Company”) (TSX: PRQ) is pleased to […]Read More
0 NYSE Companies - January 4, 2024Constellation Brands Announces Wine & Spirits Leadership TransitionRobert Hanson to Step Down as EVP & President, Wine & Spirits Division Effective February 29, 2024 Company Initiates Search […]Read More
0 NYSE Companies - January 4, 2024ADC Therapeutics gibt geschäftliche Updates bekanntZYNLONTA®1 Umsatz im 4. Quartal 2023 voraussichtlich rund 16,5 Millionen USD, ein zweistelliger Anstieg im Vergleich zum 3. Quartal 2023 LOTIS-7: […]Read More
0 NYSE Companies - January 4, 2024ADC Therapeutics erfüllt wieder die Standards für die fortgesetzte Notierung an der NYSELAUSANNE, Schweiz, Jan. 05, 2024 (GLOBE NEWSWIRE) — ADC Therapeutics SA (NYSE: ADCT) gab heute bekannt, dass das Unternehmen am […]Read More
0 NASDAQ Companies - January 4, 2024Texas Capital Bancshares, Inc. Announces Date for Full Year and Q4 2023 Operating ResultsDALLAS, Jan. 04, 2024 (GLOBE NEWSWIRE) — Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, […]Read More